News
MDXG
9.13
-1.51%
-0.14
Weekly Report: what happened at MDXG last week (1216-1220)?
Weekly Report · 3d ago
MiMedx Group, Inc. Files Patent Infringement Lawsuit Against Surgenex, LLC
Barchart · 12/17 18:12
MiMedx files patent infringement lawsuit against Surgenex
TipRanks · 12/17 14:12
MIMEDX GROUP: LAWSUIT SEEKS PERMANENT INJUNCTIVE RELIEF AND MONETARY DAMAGES
Reuters · 12/17 14:03
MIMEDX GROUP: FILES PATENT INFRINGEMENT LAWSUIT AGAINST SURGENEX
Reuters · 12/17 14:03
Weekly Report: what happened at MDXG last week (1209-1213)?
Weekly Report · 12/16 09:54
Craig-Hallum Sticks to Their Buy Rating for MiMedx Group (MDXG)
TipRanks · 12/10 13:55
Weekly Report: what happened at MDXG last week (1202-1206)?
Weekly Report · 12/09 09:53
Weekly Report: what happened at MDXG last week (1125-1129)?
Weekly Report · 12/02 09:53
Northland Securities Sticks to Its Buy Rating for MiMedx Group (MDXG)
TipRanks · 11/27 14:25
Poseida Therapeutics, Inc. (PSTX) Hit a 52 Week High, Can the Run Continue?
NASDAQ · 11/27 14:15
Weekly Report: what happened at MDXG last week (1118-1122)?
Weekly Report · 11/25 09:50
How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12%
NASDAQ · 11/20 14:55
Weekly Report: what happened at MDXG last week (1111-1115)?
Weekly Report · 11/18 09:49
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and MiMedx Group (MDXG)
TipRanks · 11/17 14:40
MIMEDX GROUP INC <MDXG.O>: CRAIG-HALLUM RAISES TARGET PRICE TO $14 FROM $12
Reuters · 11/15 15:15
Craig-Hallum Reaffirms Their Buy Rating on MiMedx Group (MDXG)
TipRanks · 11/15 14:25
Northland Securities Sticks to Their Buy Rating for MiMedx Group (MDXG)
TipRanks · 11/15 14:05
U.S. RESEARCH ROUNDUP-Applied Materials, Disney, Walmart
Reuters · 11/15 06:42
MiMedx Group, Inc. Announces Regulatory Changes Impacting Coverage for Skin Substitute Grafts
Barchart · 11/14 18:56
More
Webull provides a variety of real-time MDXG stock news. You can receive the latest news about Mimedx Group Inc through multiple platforms. This information may help you make smarter investment decisions.
About MDXG
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.